by Johns Hopkins University School of Medicine Novel cancer immunotherapy approach inverts a missing gene copy into an immune cell-activating signal. Credit: Elizabeth Cook Researchers developed a prototype for a new cancer immunotherapy that uses engineered T cells to target a genetic alteration common among all cancers. The approach, which stimulates an immune response against cells that...
